7月 2026
esaso.org
顯示 Similarweb 的估計資料。
透過連接你的 GA4 公開驗證你網站的指標
反映您的成功
連接 Google Analytics,認證您網站的流量和參與度指標
跳出率
36.81%
每次訪問頁數
2.68
平均訪問時長
00:01:03
- 公司介紹
- - -
- 行業
- - -
esaso.org 的前十大競爭對手
在 7月 2026,系統根據關鍵字流量、受眾定位與市場重疊率與 esaso.org 的相似程度,排名出 esaso.org 等前 10 名網站。
Ophthalmology was established in 1955 as a division under the Department of Surgery. We became an independent department in l987. Currently, our faculty consists of nine full-time faculty at UMMC and four full-time VA staff. There are 12 residents...
- 公司介紹
- - -
- 行業
- - -
全球排名
- -
國家/地區排名
- -
同類排名
- -
跳出率
- -
每次訪問頁數
- -
平均訪問時長
- -
As unemployment rates stay high and more people lose insurance coverage, increasing numbers of patients are asking their physicians for cheaper alternative medications. Ocular allergy is very common, with a prevalence at least four times that of nasal allergy symptoms1. Symptoms can include itching, tearing, conjunctival edema, hyperemia, burning, and discharge. While there are many different causes of bilateral conjuncitivits such as atopic and vernal, allergic is the most common type encompassing 80-90% of all types. Many prescription strength anti-allergy ophthalmic drops are available and include Bepreve (ISTA), Lastacaft (Allergan), and Patanol/Pataday (Alcon). While effective, some patients are without insurance and simply cannot afford them. That said, some of the least expensive anti-allergy drops are available over the counter. In the majority of cases, these cost less than generic prescription medications. The question is: Do they work?
- 公司介紹
- OphthalmologyWeb
- 行業
- 健康 > 醫學
跳出率
45.56%
每次訪問頁數
1.68
平均訪問時長
00:00:14
- 公司介紹
- - -
- 行業
- - -
全球排名
- -
國家/地區排名
- -
同類排名
- -
跳出率
- -
每次訪問頁數
- -
平均訪問時長
- -
esaso.org 在 7月 2026的前 5 大競爭對手是:ebo-online.org、ophthalmology.umc.edu、ophed.com、ophthalmologyweb.com 等。
根據 Similarweb 月造訪量數據,esaso.org 在 7月 2026 的主要競爭對手為 ebo-online.org。與 esaso.org 相似度排名第二的網站是 ophthalmology.umc.edu,緊隨其後位居前三的是 ophed.com。
在 7月 2026,ophthalmologyweb.com 被評為與 esaso.org 相似度第四高的網站,visioninstitute.optometry.net 則位居第五。
前十名榜單中的其他五家競爭對手分別是 、、、 和 。
